Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2003
05/01/2003US20030084484 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/01/2003US20030083500 Imidazonaphthyridines
05/01/2003US20030083499 Pyridomorphinans and use thereof
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor
05/01/2003US20030083369 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity
05/01/2003US20030083363 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
05/01/2003US20030083352 Cyclization of a 2-cyano-2-ester-ethylenamine with a primary amine to a 4-ester imidazole
05/01/2003US20030083347 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same
05/01/2003US20030083345 Method of treatment and/or prevention of brain, spinal or nerve injury
05/01/2003US20030083344 Tryptase inhibitors
05/01/2003US20030083343 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
05/01/2003US20030083335 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
05/01/2003US20030083333 1,4-Disubstituted benzo-fused compounds
05/01/2003US20030083332 N-heterocyclic derivatives as NOS inhibitors
05/01/2003US20030083315 Benzimidazole derivatives for treating an inflammatory disease, an allergy disease, a respiratory disease, a cardiovascular disorder or a bone disorder
05/01/2003US20030083296 Antisense modulation of caspase 8 expression
05/01/2003US20030083295 An oligonucleotides are hybridizable with nucleic acids to inhibit the gene expression of enzyme
05/01/2003US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
05/01/2003US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease
05/01/2003US20030083265 TGF-beta inhibitors and methods
05/01/2003US20030083256 Compositions and methods for enhancing drug delivery across and into epithelial tissues
05/01/2003US20030083254 Heparanase-like proteins and nucleotides that encode them
05/01/2003US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule
05/01/2003US20030083239 Hexapeptide capable of inhibiting beta-chemokine from binding to CCR3 receptor; for treating subject with a disease associated with aberrant leukocyte recruitment and/or activation
05/01/2003US20030083236 Myelopeptides and their therapeutic use
05/01/2003US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents
05/01/2003US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082554 Nucleotide sequences coding polypeptide for use in the treatment of immunlological, thyroid, metabolic, bone and pancreatic disorders
05/01/2003US20030082213 Use of microparticles combined with submicron oil-in-water emulsions
05/01/2003US20030082207 Method of using HIV protease inhibiting compounds
05/01/2003US20030082195 Method of enhancing an immune response
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082184 Uses of mammalian cytokine; related reagents
05/01/2003US20030082171 Deafness therapy, prevention; mylein protein vaccine
05/01/2003US20030082151 Extension of the expression of transgenic proteins by immunomodulation
05/01/2003US20030082143 Filamentous phage particles having a ligand on surface for delivering a therapeutic gene to a cell; gene therapy
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2498591A1 Immunotherapy for reversing immune suppression
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2464606A1 Method of modulating the immunoactivity of an immunocompetent graft by progenipoietin
05/01/2003CA2464593A1 6-hydroxy isoflavones, derivatives and medicaments involving same
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464344A1 Ee3-protein family and corresponding dna sequences
05/01/2003CA2464254A1 Inhibitors of post-proline cleaving proteases
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases
05/01/2003CA2464085A1 A combination product comprising melagatran and dexamethasone
05/01/2003CA2463951A1 Solid pharmaceutical formulation for a piperazine urea derivative
05/01/2003CA2463101A1 Azole derivatives and pharmaceutical compositions containing them
05/01/2003CA2463043A1 Combination of liponic acid and glutamine in food and pharmaceutical products
05/01/2003CA2460665A1 Peptides and proteins binding to glu-pro motifs, therapeutical compositions containing them and their applications
05/01/2003CA2458542A1 Enzyme inhibitors for inactivating allergens
04/2003
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414971A Depsipeptide and congeners thereof for use as immunosuppressants
04/30/2003CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin
04/30/2003CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof
04/30/2003CN1414954A Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
04/30/2003CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions
04/30/2003CN1414864A Adhesive particle DNA constructs and method of making and using the same
04/30/2003CN1414861A Induction of mucosal immunity by vaccination via skin nute
04/30/2003CN1414855A Remedies for external use for allergic skin diseases
04/30/2003CN1413667A Health-care food with fatigue resistance, regulating immunologic function and its preparation method
04/30/2003CN1413641A Chinese herbal medicine prescription for radical curing toxic type allergic dermatitis
04/30/2003CN1413630A Medicine for treating over sexual intercourse, work at night, tired, poor memory, body hypoimmunity and endocrine function disturbance
04/30/2003CN1413589A Composition of paeoniflorin and albiflorin and its preparation method
04/30/2003CN1413581A Pharmaceutical preparation containing northeast cryrtominetin medicinal preparation and its new use
04/30/2003CN1107072C Programing cell death induced molecule II
04/30/2003CN1107068C 2-amino-7-(1-substituted-2-hyroxyethyl)-3.5-diphydro-pyrrolo (3,2-D) pyrimidine-4-ones
04/30/2003CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists
04/30/2003CN1107059C Azole derivative
04/30/2003CN1107058C Subsitituted isoxazoles for treatment of inflammation
04/30/2003CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases
04/29/2003US6555827 Method of determining variations in the properties of a sample
04/29/2003US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α
04/29/2003US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery
04/29/2003US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/29/2003US6555651 Ligand binding site of rage and uses thereof
04/29/2003US6555562 2-Carboxybenzoyl-(N'-3,5-dichloroisonicotinoyl)-L-4aminophenyl alanine, for example; inhibit the binding of alpha-4 integrins to their ligands, use to treat immune or inflammatory disorders
04/29/2003US6555558 Oral dosage self-emulsifying formulations of pyranone protease inhibitors
04/29/2003US6555545 Adenosine, caffeine, and 8-styryl-1,3,7-alkyl xanthine derivatives as wound healing agents
04/29/2003US6555543 Inhibiting the effects of platelet activating factor (PAF).
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions
04/29/2003US6555527 Hematopoietic, myeloprotecting, antitumor immune cells generating and radiosensitizing polysaccharide isolated from Panax ginseng
04/29/2003US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/29/2003US6555132 Soft gelatin capsule manufacture
04/29/2003US6555116 Hypo-allergenic pollen protein that has been treated with thioredoxin, nicotinamide adenine dinucleotide phosphate-thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH).
04/29/2003US6555114 Immunodominant human T-cell epitopes of hepatitis C virus
04/29/2003US6555105 Method of treatment with a RANTES antagonist polypeptide
04/29/2003CA2121369C Inhibitors of dipeptidyl-aminopeptidase type iv
04/26/2003CA2409084A1 Anti-inflammatory agent and foods and drinks containing the same
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003034067A1 Modulation of tor
04/24/2003WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
04/24/2003WO2003033681A2 Composition comprising a lactobacillus pentosus strain and uses thereof
1 ... 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 ... 1172